Denali Therapeutics Inc. (DNLI)
NASDAQ · Healthcare
Denali Therapeutics Inc. Total Liabilities 2016–2025
Denali Therapeutics Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Denali Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 131.1M, a 9.28% decrease year-over-year.
- Denali Therapeutics Inc. total liabilities for 2025 were 131.1M, a 9.28% decrease from 2024.
- Denali Therapeutics Inc. total liabilities for 2024 were 144.5M, a 17.51% increase from 2023.
- Denali Therapeutics Inc. total liabilities for 2023 were 123.0M, a 70.57% decrease from 2022.
- Denali Therapeutics Inc. total liabilities for 2022 were 417.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Denali Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $131 |
| 2024 | $144 |
| 2023 | $123 |
| 2022 | $418 |
| 2021 | $442 |
| 2020 | $454 |
| 2019 | $158 |
| 2018 | $115 |
| 2017 | $21 |
| Denali Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $131 |
| 2024-12-31 | $144 |
| 2023-12-31 | $123 |
| 2022-12-31 | $418 |
| 2021-12-31 | $442 |
| 2020-12-31 | $454 |
| 2019-12-31 | $158 |
| 2018-12-31 | $115 |
| 2017-12-31 | $21 |
Denali Therapeutics Inc. Total Liabilities — FAQ
Denali Therapeutics Inc. (DNLI) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNLI's total liabilities history?
The chart and table above show Denali Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.